Please enable JavaScript to continue using this application.

Compare $CRL vs $WST | Chartloom

Compare

$CRL vs $WST

Charles River Laboratories International Inc · West Pharmaceutical Services Inc

CRL

Charles River Laboratories International Inc

WST

West Pharmaceutical Services Inc

Compare $CRL vs $WST

Comparing Charles River Laboratories International Inc and West Pharmaceutical Services Inc

CRLCharles River Laboratories International Inc

WSTWest Pharmaceutical Services Inc

CRLCharles River Laboratories International Inc

Market cap

$14.54B

P/E (TTM)

—

Forward P/E (NTM)

24.21x

Forward P/S (NTM)

3.68x

Rev growth (TTM)

-0.7%

YTD performance

49.1%

52W performance

74.0%

FCF yield

2.5%

WSTWest Pharmaceutical Services Inc

Market cap

$25.76B

P/E (TTM)

46.20x

Forward P/E (NTM)

39.00x

Forward P/S (NTM)

7.45x

Rev growth (TTM)

12.4%

YTD performance

32.4%

52W performance

36.6%

FCF yield

1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRL

WST

Detailed metrics comparison

CRL

Charles River Laboratories International Inc

WST

West Pharmaceutical Services Inc

Market Cap

CRL$14.54B

WST$25.76B

Enterprise Value

CRL$16.97B

WST$25.53B

Price

CRL$301.79

WST$366.00

P/E Ratio

CRLN/A

WST46.20x

P/S Ratio

CRL3.64x

WST7.74x

EV/Sales

CRL4.24x

WST7.67x

EV/EBITDA

CRL19.41x

WST28.16x

P/B Ratio

CRL4.88x

WST8.84x

P/FCF Ratio

CRL39.23x

WST58.96x

EV/FCF

CRL45.79x

WST58.44x

PEG Ratio

CRLN/A

WST3.05x

Forward P/E (NTM)

CRL24.21x

WST39.00x

Forward P/S (NTM)

CRL3.68x

WST7.45x

Revenue (TTM)

CRL$4.00B

WST$3.33B

Revenue Growth (YoY)

CRL-0.7%

WST12.4%

Forward Rev Growth

CRL2.3%

WST6.2%

Gross Margin (TTM)

CRL34.6%

WST36.8%

Operating Margin (TTM)

CRL2.3%

WST20.4%

EBITDA Margin (TTM)

CRL21.6%

WST27.0%

Net Margin (TTM)

CRL-6.0%

WST17.0%

FCF Margin (TTM)

CRL9.3%

WST13.1%

Net Income (TTM)

CRL$-238M

WST$565M

FCF (TTM)

CRL$371M

WST$437M

EPS (TTM)

CRL-$4.97

WST$7.92

ROE (TTM)

CRL-772.0%

WST18.5%

ROA (TTM)

CRL-319.0%

WST13.6%

ROIC (TTM)

CRL-434.0%

WST17.3%

Cash

CRL$192M

WST$436M

Debt

CRL$2.63B

WST$207M

Net Cash/Debt

CRL$-2.43B

WST$229M

Current Ratio (TTM)

CRL1.35x

WST2.82x

Quick Ratio (TTM)

CRL0.83x

WST2.12x

Debt/Equity (TTM)

CRL0.93x

WST0.07x

Debt/Assets (TTM)

CRL0.0%

WST0.0%

Interest Coverage (TTM)

CRLN/A

WSTN/A

Net Debt/EBITDA (TTM)

CRL0.00x

WST0.00x

Beta

CRL1.38

WST1.15

52W Performance

CRL74.0%

WST36.6%

YTD Performance

CRL49.1%

WST32.4%

% from 52W High

CRL-9.5%

WST-5.2%

% from 52W Low

CRL106.4%

WST63.5%

Asset Turnover (TTM)

CRL0.53x

WST0.80x

FCF Yield (TTM)

CRL2.5%

WST1.7%

Earnings Yield (TTM)

CRL-1.6%

WST2.2%

Dividend Yield (TTM)

CRLN/A

WST0.2%

Rule of 40

CRL8.5

WST25.5

EV/GP/RG

CRL5.20

WST5.32

Ticker research

View CRL research View WST research

Metric	CRL Charles River Laboratories International Inc	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$14.54B	$25.76B
Enterprise Value	$16.97B	$25.53B
Price	$301.79	$366.00
P/E Ratio	N/A	46.20x
P/S Ratio	3.64x	7.74x
EV/Sales	4.24x	7.67x
EV/EBITDA	19.41x	28.16x
P/B Ratio	4.88x	8.84x
P/FCF Ratio	39.23x	58.96x
EV/FCF	45.79x	58.44x
PEG Ratio	N/A	3.05x
Forward P/E (NTM)	24.21x	39.00x
Forward P/S (NTM)	3.68x	7.45x
Revenue & Growth
Revenue (TTM)	$4.00B	$3.33B
Revenue Growth (YoY)	-0.7%	12.4%
Forward Rev Growth	2.3%	6.2%
Profitability
Gross Margin (TTM)	34.6%	36.8%
Operating Margin (TTM)	2.3%	20.4%
EBITDA Margin (TTM)	21.6%	27.0%
Net Margin (TTM)	-6.0%	17.0%
FCF Margin (TTM)	9.3%	13.1%
Net Income (TTM)	$-238M	$565M
FCF (TTM)	$371M	$437M
EPS (TTM)	-$4.97	$7.92
ROE (TTM)	-772.0%	18.5%
ROA (TTM)	-319.0%	13.6%
ROIC (TTM)	-434.0%	17.3%
Financial Health
Cash	$192M	$436M
Debt	$2.63B	$207M
Net Cash/Debt	$-2.43B	$229M
Current Ratio (TTM)	1.35x	2.82x
Quick Ratio (TTM)	0.83x	2.12x
Debt/Equity (TTM)	0.93x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.38	1.15
52W Performance	74.0%	36.6%
YTD Performance	49.1%	32.4%
% from 52W High	-9.5%	-5.2%
% from 52W Low	106.4%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	0.53x	0.80x
FCF Yield (TTM)	2.5%	1.7%
Earnings Yield (TTM)	-1.6%	2.2%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	8.5	25.5
EV/GP/RG	5.20	5.32
Ticker research	View CRL research	View WST research

Valuation

P/E Ratio

WST

46.20x

P/S Ratio

CRL

3.64x

WST

7.74x

EV/FCF

CRL

45.79x

WST

58.44x

Growth & revenue

Revenue Growth TTM

WST

12.4%

CRL

-0.7%

Forward Revenue Growth

WST

6.2%

CRL

2.3%

Profitability & performance

Gross Margin

WST

36.8%

CRL

34.6%

ROE

WST

18.5%

CRL

-772.0%

FCF Yield %

CRL

2.5%

WST

1.7%

52-Week Performance

CRL

74.0%

WST

36.6%

Detailed metrics comparison

CRL

Charles River Laboratories International Inc

WST

West Pharmaceutical Services Inc

Market Cap

CRL$14.54B

WST$25.76B

Enterprise Value

CRL$16.97B

WST$25.53B

Price

CRL$301.79

WST$366.00

P/E Ratio

CRLN/A

WST46.20x

P/S Ratio

CRL3.64x

WST7.74x

EV/Sales

CRL4.24x

WST7.67x

EV/EBITDA

CRL19.41x

WST28.16x

P/B Ratio

CRL4.88x

WST8.84x

P/FCF Ratio

CRL39.23x

WST58.96x

EV/FCF

CRL45.79x

WST58.44x

PEG Ratio

CRLN/A

WST3.05x

Forward P/E (NTM)

CRL24.21x

WST39.00x

Forward P/S (NTM)

CRL3.68x

WST7.45x

Revenue (TTM)

CRL$4.00B

WST$3.33B

Revenue Growth (YoY)

CRL-0.7%

WST12.4%

Forward Rev Growth

CRL2.3%

WST6.2%

Gross Margin (TTM)

CRL34.6%

WST36.8%

Operating Margin (TTM)

CRL2.3%

WST20.4%

EBITDA Margin (TTM)

CRL21.6%

WST27.0%

Net Margin (TTM)

CRL-6.0%

WST17.0%

FCF Margin (TTM)

CRL9.3%

WST13.1%

Net Income (TTM)

CRL$-238M

WST$565M

FCF (TTM)

CRL$371M

WST$437M

EPS (TTM)

CRL-$4.97

WST$7.92

ROE (TTM)

CRL-772.0%

WST18.5%

ROA (TTM)

CRL-319.0%

WST13.6%

ROIC (TTM)

CRL-434.0%

WST17.3%

Cash

CRL$192M

WST$436M

Debt

CRL$2.63B

WST$207M

Net Cash/Debt

CRL$-2.43B

WST$229M

Current Ratio (TTM)

CRL1.35x

WST2.82x

Quick Ratio (TTM)

CRL0.83x

WST2.12x

Debt/Equity (TTM)

CRL0.93x

WST0.07x

Debt/Assets (TTM)

CRL0.0%

WST0.0%

Interest Coverage (TTM)

CRLN/A

WSTN/A

Net Debt/EBITDA (TTM)

CRL0.00x

WST0.00x

Beta

CRL1.38

WST1.15

52W Performance

CRL74.0%

WST36.6%

YTD Performance

CRL49.1%

WST32.4%

% from 52W High

CRL-9.5%

WST-5.2%

% from 52W Low

CRL106.4%

WST63.5%

Asset Turnover (TTM)

CRL0.53x

WST0.80x

FCF Yield (TTM)

CRL2.5%

WST1.7%

Earnings Yield (TTM)

CRL-1.6%

WST2.2%

Dividend Yield (TTM)

CRLN/A

WST0.2%

Rule of 40

CRL8.5

WST25.5

EV/GP/RG

CRL5.20

WST5.32

Ticker research

View CRL research View WST research

Metric	CRL Charles River Laboratories International Inc	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$14.54B	$25.76B
Enterprise Value	$16.97B	$25.53B
Price	$301.79	$366.00
P/E Ratio	N/A	46.20x
P/S Ratio	3.64x	7.74x
EV/Sales	4.24x	7.67x
EV/EBITDA	19.41x	28.16x
P/B Ratio	4.88x	8.84x
P/FCF Ratio	39.23x	58.96x
EV/FCF	45.79x	58.44x
PEG Ratio	N/A	3.05x
Forward P/E (NTM)	24.21x	39.00x
Forward P/S (NTM)	3.68x	7.45x
Revenue & Growth
Revenue (TTM)	$4.00B	$3.33B
Revenue Growth (YoY)	-0.7%	12.4%
Forward Rev Growth	2.3%	6.2%
Profitability
Gross Margin (TTM)	34.6%	36.8%
Operating Margin (TTM)	2.3%	20.4%
EBITDA Margin (TTM)	21.6%	27.0%
Net Margin (TTM)	-6.0%	17.0%
FCF Margin (TTM)	9.3%	13.1%
Net Income (TTM)	$-238M	$565M
FCF (TTM)	$371M	$437M
EPS (TTM)	-$4.97	$7.92
ROE (TTM)	-772.0%	18.5%
ROA (TTM)	-319.0%	13.6%
ROIC (TTM)	-434.0%	17.3%
Financial Health
Cash	$192M	$436M
Debt	$2.63B	$207M
Net Cash/Debt	$-2.43B	$229M
Current Ratio (TTM)	1.35x	2.82x
Quick Ratio (TTM)	0.83x	2.12x
Debt/Equity (TTM)	0.93x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.38	1.15
52W Performance	74.0%	36.6%
YTD Performance	49.1%	32.4%
% from 52W High	-9.5%	-5.2%
% from 52W Low	106.4%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	0.53x	0.80x
FCF Yield (TTM)	2.5%	1.7%
Earnings Yield (TTM)	-1.6%	2.2%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	8.5	25.5
EV/GP/RG	5.20	5.32
Ticker research	View CRL research	View WST research